Berlin, Germany

Verena Fetz

This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignee: Helmholtz-Zentrum Fuer Infektionsforschung Gmbh. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Verena Fetz. Retrieved from https://idiyas.com/inventor/verena-fetz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1


Location History:

  • Braunschweig, DE (2021)
  • Berlin, DE (2022)

Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Verena Fetz - Innovative Inventor from Berlin

Introduction: Verena Fetz is a pioneering inventor based in Berlin, Germany, known for her groundbreaking contributions to various fields of technology and science.

Latest Patents: Verena Fetz holds several patents in the areas of renewable energy, sustainable materials, and biotechnology, showcasing her commitment to creating solutions for a more sustainable future.

Career Highlights: With a career spanning over two decades, Verena Fetz has worked with leading research institutions and universities to develop cutting-edge technologies that have the potential to revolutionize industries worldwide.

Collaborations: Verena Fetz has collaborated with multinational companies, innovative startups, and renowned scientists to bring her inventions to life, demonstrating her ability to work across diverse teams and disciplines.

Conclusion: Verena Fetz's passion for innovation and her dedication to creating impactful solutions highlight her as a prominent figure in the world of inventors, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…